+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Collegium Pharmaceutical Inc - logo

Collegium Pharmaceutical is a specialty pharmaceutical company developing and commercializing next generation, abuse-deterrent products for patients suffering from chronic pain. The company has developed a novel, patented, abuse-deterrent technology platform, DETERx, which provides extended-release drug delivery. It was formerly known as Collegium Pharmaceuticals and changed its name to Collegium Pharmaceutical in October 2003. Collegium Pharmaceutical was incorporated in 2002 and is headquartered in Canton, Massachusetts.

Opioid Use Disorder (OUD) Global Market Report 2024 - Product Thumbnail Image

Opioid Use Disorder (OUD) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Chronic Pain Global Market Report 2024 - Product Thumbnail Image

Chronic Pain Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Global Controlled-Release Drug Delivery Market - Opportunity & Clinical Trial Outlook 2025 - Product Thumbnail Image

Global Controlled-Release Drug Delivery Market - Opportunity & Clinical Trial Outlook 2025

  • Report
  • November 2018
  • 700 Pages
  • Global
From
Low Back Pain Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Low Back Pain Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • February 2020
  • 486 Pages
  • Global
From
Upper Respiratory Tract Infection Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Upper Respiratory Tract Infection Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 93 Pages
  • Global
From
Anti-Allergy Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Allergy Drugs - Global Strategic Business Report

  • Report
  • April 2024
  • 86 Pages
  • Global
From
Abuse Deterrent Formulation Technologies Market, 2019-2030 - Product Thumbnail Image

Abuse Deterrent Formulation Technologies Market, 2019-2030

  • Report
  • July 2019
  • 280 Pages
  • Global
From
Global Controlled Release Drug Delivery Market by Release Mechanism (Activation-Modulated Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems), Technology (Coacervation, Implants, Micro Encapsulation), Application - Forecast 2023-2030 - Product Thumbnail Image

Global Controlled Release Drug Delivery Market by Release Mechanism (Activation-Modulated Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems), Technology (Coacervation, Implants, Micro Encapsulation), Application - Forecast 2023-2030

  • Report
  • March 2024
  • 181 Pages
  • Global
From
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 300 Pages
  • Global
From
Overactive Bladder Treatment Global Market Report 2024 - Product Thumbnail Image

Overactive Bladder Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2019-2024

  • Report
  • April 2024
  • 700 Pages
  • Global
From
Controlled Release Drug Delivery Global Market Report 2024 - Product Thumbnail Image

Controlled Release Drug Delivery Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Global Controlled Release Drug Delivery Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Thumbnail Image

Global Controlled Release Drug Delivery Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • February 2024
  • 201 Pages
  • Global
From
Controlled Release Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Controlled Release Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 99 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2020 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 184 Pages
  • Global
From
Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence - Product Thumbnail Image

Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022 - Thematic Intelligence

  • Report
  • February 2023
  • 22 Pages
  • Global
From
Collegium Pharmaceutical Inc (COLL:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Collegium Pharmaceutical Inc (COLL:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Collegium Pharmaceutical (COLL:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Collegium Pharmaceutical (COLL:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • April 2022
  • 79 Pages
From
Comprehensive Report on Collegium Pharmaceutical Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Collegium Pharmaceutical Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • April 2023
  • 53 Pages
From
Loading Indicator